Time for contrast material to traverse the epicardial artery and the myocardium in ST-segment elevation acute myocardial infarction versus unstable angina pectoris/non-ST-elevation acute myocardial infarction

American Journal of Cardiology

Volumn 91, Issue 10, 2003, Pages 1163-1167

  Wong, Graham C ^b   Frisch, Daniel ^b   Murphy, Sabina A ^b   Sabatine, Marc S ^b   Pai, Rupal ^b   James, David ^b   Kraimer, Nicole ^b   Katsiyiannis, Peter T ^b   Marble, Susan J ^b   DiBattiste, Peter M ^b   Demopoulos, Laura A ^b   Gourlay, Steven G ^b   Barron, Hal V ^b   Cannon, Christopher P ^b   Gibson, C Michael ^a  

^a TIMI Data Coordinating Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG TRANSPORT; FEMALE; HEART MUSCLE; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STENOSIS; THROMBUS; TIME; UNSTABLE ANGINA PECTORIS;

EID: 0038064222     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00260-1     Document Type: Article

References (26)

1. Simes R.J., Topol E.J., Holmes D.R. Jr, White H.D., Rutsch W.R., Vahanian A., Simoons M.L., Morris D., Betriu A., Califf R.M., et al. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation. 91:1995;1923-1928.
2. The comparative effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med. 329:1993;1615-1622.
3. The Thrombolysis in Myocardial Infarction (TIMI) trial; phase I findings. N Engl J Med. 312:1985;932-936.
4. Gibson C.M., Ryan K.A., Kelley M.B., Sparano A.M., Marble S.J., de Lemos J.A., Mattson S., Cannon C.P. Slower global flow in all 3 epicardial arteries after thrombolysis is related to adverse outcomes. Circulation. 98:(suppl. I):1998;I-698.
5. Santoro G.M., Valenti R., Buonamici P., Bolognese L., Cerisano G., Moschi G., Trapani M., Antoniucci D., Fazzini P.F. Relation between ST-segment changes and myocardial perfusion evaluated by myocardial contrast echocardiography in patients with acute myocardial infarction treated with direct angioplasty. Am J Cardiol. 82:1998;932-937.
6. de Lemos J.A. ST-segment resolution as a marker of epicardial and myocardial reperfusion after thrombolysis insights from the TIMI 14 and in TIME-II trials . J Electrocardiol. 33:2000;67-72.
7. Gibson C.M., Cannon C.P., Murphy S.A., Ryan K.A., Mesley R., Marble S.J., McCabe C.H., Van de Werf F., Braunwald E. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation. 101:2000;125-130.
8. Gibson C.M., Murphy S., Menown I.B., Sequeira R.F., Greene R., Van de Werf F., Schweiger M.J., Ghali M., Frey M.J., Ryan K.A., et al. Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group Thrombolysis in Myocardial Infarction. J Am Coll Cardiol. 34:1999;1403-1412.
9. Cannon C.P., Weintraub W.S., Demopoulos L.A., Vicari R., Frey M.J., Lakkis N., Neumann F.J., Robertson D.H., DeLucca P.T., DiBattiste P.M., Gibson C.M., Braunwald E. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 344:2001;1879-1887.
10. Baran K.W., Nguyen M., McKendall G.R., Lambrew C.T., Dykstra G., Palmeri S.T., Gibbons R.J., Borzak S., Sobel B.E., Gourlay S.G., et al. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction limitation of myocardial infarction following Thrombolysis in Acute Myocardial Infarction (LIMIT AMI) study . Circulation. 104:2001;2778-2783.
11. Gibson C.M., Cannon C.P., Daley W.L., Dodge J.T. Jr, Alexander B. Jr, Marble S.J., McCabe C.H., Raymond L., Fortin T., Poole W.K., Braunwald E. TIMI frame count a quantitative method of assessing coronary artery flow . Circulation. 93:1996;879-888.
12. Rupprecht H.J., Sohn H.Y., Kearney P., Bickel C., Nafe B., Meyer J. Clinical predictors of unstable coronary lesion morphology. Eur Heart J. 16:1995;1526-1534.
13. Dangas G., Mehran R., Wallenstein S., Courcoutsakis N.A., Kakarala V., Hollywood J., Ambrose J.A. Correlation of angiographic morphology and clinical presentation in unstable angina. J Am Coll Cardiol. 29:1997;519-525.
14. Goodman S.G., Langer A., Ross A.M., Wildermann N.M., Barbagelata A., Sgarbossa E.B., Wagner G.S., Granger C.B., Califf R.M., Topol E.J., Simoons M.L., Armstrong P.W. Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators . Circulation. 97:1998;444-450.
15. Gibson C.M., Murphy S., Pai R., Kraimer N., Weisberg S., De Feo T., Marble S.J., Angeja B., Robertson D.H., Demopoulos L.A., DiBattiste P.M., Morrow D.A. Elevations in troponin T are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Circulation. 104:(suppl II):2001;II-708.
16. Gibson C.M., Murphy S.A., Marble S.J., Cohen D.J., Cohen E.A., Lui H.K., Young J. Jr, Kitt M.M., Lorenz T.J., Tcheng J.E. Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement an ESPRIT substudy . Am Heart J. 143:2002;106-110.
17. Maxwell L., Harrison W.R., Gavin J.B. Endothelin antagonists diminish postischemic microvascular incompetence and necrosis in the heart. Microvasc Res. 59:2000;204-212.
18. Farber J.L., Chien K.R., Mittnacht S. Jr. Myocardial ischemia the pathogenesis of irreversible cell injury in ischemia . Am J Pathol. 102:1981;271-281.
19. Kloner R.A., Ganote C.E., Jennings R.B. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 54:1974;1496-1508.
20. Pinckard R.N., O'Rourke R.A., Crawford M.H., Grover F.S., McManus L.M., Ghidoni J.J., Storrs S.B., Olson M.S. Complement localization and mediation of ischemic injury in baboon myocardium. J Clin Invest. 66:1980;1050-1056.
21. Weisman H.F., Bartow T., Leppo M.K., Marsh H.C. Jr, Carson G.R., Concino M.F., Boyle M.P., Roux K.H., Weisfeldt M.L., Fearon D.T. Soluble human complement receptor type 1 in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis . Science. 249:1990;146-151.
22. Sheridan F.M., Cole P.G., Ramage D. Leukocyte adhesion to the coronary microvasculature during ischemia and reperfusion in an in vivo canine model. Circulation. 93:1996;1784-1787.
23. Iliceto S., Marangelli V., Marchese A., Amico A., Galiuto L., Rizzon P. Myocardial contrast echocardiography in acute myocardial infarction. Pathophysiological background and clinical applications. Eur Heart J. 17:1996;344-353.
24. Kiyak J.H., Zerbino D.D. Pathogenesis and morphogenesis of microcirculatory disorders in myocardial infarction. Clinical and ultrastructural examination. Pol J Pathol. 47:1996;27-32.
25. Marzilli M., Sambuceti G., Fedele S., L'Abbate A. Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina. J Am Coll Cardiol. 35:2000;327-334.
26. Christiansen J.P., Leong-Poi H., Fisher N.G., Klibanov A.L., Kaul S., Lindner J.R. Non-invasive imaging of myocardial inflammation following reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation. 104:(suppl II):2001;II-589.